Time-to-treatment failure of 202 chronic lymphocytic leukemia (CLL) patients treated with fludarabine, cyclophosphamide, and rituximab (FCR) as initial therapy according to response (NCIWG criteria).

Abbreviations: CR, complete response; PR, partial response; NR, no response; NCIWG, National Cancer Institute Working Group.